Ras-induced serine phosphorylation of the focal adhesion protein paxillin is mediated by the Raf→MEK→ERK pathway

Experimental Cell Research

Volumn 287, Issue 2, 2003, Pages 325-338

  Woodrow, Melissa A ^a   Woods, Douglas ^a   Cherwinski, Holly M ^b   Stokoe, David ^a   McMahon, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cytoskeleton; Paxillin; Phosphorylation; Raf; Ras; Transformation

Indexed keywords

ADAPTOR PROTEIN; ALANINE; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PAXILLIN; RAF PROTEIN; RAS PROTEIN; SERINE; TYROSINE; CYTOSKELETON PROTEIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; PXN PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL SUSPENSION; CELL TYPE; CONTROLLED STUDY; EMBRYO; FOCAL ADHESION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CELL STRAIN 3T3; GENETICS; METABOLISM; MOLECULAR GENETICS; ONCOGENE RAS; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY;

MAMMALIA;

3T3 CELLS; ALANINE; AMINO ACID SEQUENCE; ANIMALS; CYTOSKELETAL PROTEINS; FOCAL ADHESIONS; GENES, RAS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MUTATION; PAXILLIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; SIGNAL TRANSDUCTION;

EID: 0041703122     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00122-8     Document Type: Article

References (73)

1. Bos J.L. ras oncogenes in human cancer a review. Cancer Res. 49:1989;4682-4689.
2. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A., Nicholson A., Ho J.W., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A. Mutations of the BRAF gene in human cancer. Nature. 417:2002;949-954.
3. Dankort D.L., Muller W.J. Signal transduction in mammary tumorigenesis a transgenic perspective. Oncogene. 19:2000;1038-1044.
4. Dankort D., Jeyabalan N., Jones N., Dumont D.J., Muller W.J. Multiple ErbB-2/Neu phosphorylation sites mediate transformation through distinct effector proteins. J. Biol. Chem. 276:2001;38921-38928.
5. Cortez D., Reuther G., Pendergast A.M. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells. Oncogene. 15:1997;2333-2342.
6. Aziz N., Cherwinski H., McMahon M. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Mol. Cell. Biol. 19:1999;1101-1115.
7. Troppmair J., Bruder J.T., Munoz H., Lloyd P.A., Kyriakis J., Banerjee P., Avruch J., Rapp U.R. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem. 269:1994;7030-7035.
8. Woods D., Cherwinski H., Venetsanakos E., Bhat A., Gysin S., Humbert M., Bray P.F., Saylor V.L., McMahon M. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway. Mol. Cell. Biol. 21:2001;3192-3205.
9. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:1998;2997-3007.
10. Samuels M.L., Weber M.J., Bishop J.M., McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13:1993;6241-6252.
11. Hansen S.H., Zegers M.M., Woodrow M., Rodriguez-Viciana P., Chardin P., Mostov K.E., McMahon M. Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway. Mol. Cell. Biol. 20:2000;9364-9375.
12. Hughes P.E., Renshaw M.W., Pfaff M., Forsyth J., Keivens V.M., Schwartz M.A., Ginsberg M.H. Suppression of integrin activation a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell. 88:1997;521-530.
13. Clark E.A., Brugge J.S. Integrins and signal transduction pathways the road taken. Science. 268:1995;233-239.
14. Craig S.W., Johnson R.P. Assembly of focal adhesions progress, paradigms, and portents. Curr. Opin. Cell Biol. 8:1996;74-85.
15. Schwartz M.A., Schaller M.D., Ginsberg M.H. Integrins emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11:1995;549-599.
16. Schaller M.D., Otey C.A., Hildebrand J.D., Parsons J.T. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J. Cell Biol. 130:1995;1181-1187.
17. Schaller M.D., Parsons J.T. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol. Cell. Biol. 15:1995;2635-2645.
18. Schaller M.D. Paxillin a focal adhesion-associated adaptor protein. Oncogene. 20:2001;6459-6472.
19. Tanaka T., Yamaguchi R., Sabe H., Sekiguchi K., Healy J.M. Paxillin association in vitro with integrin cytoplasmic domain peptides. FEBS Lett. 399:1996;53-58.
20. Han J., Liu S., Rose D.M., Schlaepfer D.D., McDonald H., Ginsberg M.H. Phosphorylation of the integrin alpha 4 cytoplasmic domain regulates paxillin binding. J. Biol. Chem. 276:2001;40903-40909.
21. Lipfert L., Haimovich B., Schaller M.D., Cobb B.S., Parsons J.T., Brugge J.S. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J. Cell Biol. 119:1992;905-912.
22. Burridge K., Turner C.E., Romer L.H. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix a role in cytoskeletal assembly. J. Cell Biol. 119:1992;893-903.
23. Woods D., Parry D., Cherwinski H., Bosch E., Lees E., McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:1997;5598-5611.
24. McCarthy S.A., Samuels M.L., Pritchard C.A., Abraham J.A., McMahon M. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9:1995;1953-1964.
25. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
26. Boyle W.J., van der Geer P., Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:1991;110-149.
27. Wettenhall R.E., Aebersold R.H., Hood L.E. Solid-phase sequencing of 32P-labeled phosphopeptides at picomole and subpicomole levels. Methods Enzymol. 201:1991;186-199.
28. Stokoe D., Campbell D.G., Nakielny S., Hidaka H., Leevers S.J., Marshall C., Cohen P. MAPKAP kinase-2 a novel protein kinase activated by mitogen-activated protein kinase. Embo J. 11:1992;3985-3994.
29. Liu Y.C., Kawagishi M., Mikayama T., Inagaki Y., Takeuchi T., Ohashi H. Processing of a fusion protein by endoprotease in COS-1 cells for secretion of mature peptide by using a chimeric expression vector. Proc. Natl. Acad. Sci. USA. 90:1993;8957-8961.
30. McMahon M., Schatzman R.C., Bishop J.M. The amino-terminal 14 amino acids of v-src can functionally replace the extracellular and transmembrane domains of v-erbB. Mol. Cell. Biol. 11:1991;4760-4770.
31. Izawa I., Amano M., Chihara K., Yamamoto T., Kaibuchi K. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation. Oncogene. 17:1998;2863-2871.
32. Chen D., Heath V., O'Garra A., Johnston J., McMahon M. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells. J. Immunol. 163:1999;5796-5805.
33. Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M., McCormick F. Opposing effects of Ras on p53 transcriptional activation of mdm2 and induction of p19ARF. Cell. 103:2000;321-330.
34. Cook S.J., Aziz N., McMahon M. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19:1999;330-341.
35. Pritchard C.A., Samuels M.L., Bosch E., McMahon M. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:1995;6430-6442.
36. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
37. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
38. Glenney J.R. Jr., Zokas L. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell Biol. 108:1989;2401-2408.
39. Turner C.E., Glenney J.R. Jr., Burridge K. Paxillin a new vinculin-binding protein present in focal adhesions. J. Cell Biol. 111:1990;1059-1068.
40. Turner C.E. Paxillin and focal adhesion signalling. Nat. Cell Biol. 2:2000;E231-E236.
41. Turner C.E. Paxillin interactions. J. Cell Sci. 113:2000;4139-4140.
42. Ku H., Meier K.E. Phosphorylation of paxillin via the ERK mitogen-activated protein kinase cascade in EL4 thymoma cells. J. Biol. Chem. 275:2000;11333-11340.
43. Liu Z.X., Yu C.F., Nickel C., Thomas S., Cantley L.G. Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association. J. Biol. Chem. 277:2002;10452-10458.
44. Sahai E., Olson M.F., Marshall C.J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. Embo J. 20:2001;755-766.
45. Pawlak G., Helfman D.M. Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. Mol. Biol. Cell. 13:2002;336-347.
46. Pawlak G., Helfman D.M. MEK mediates v-src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway. J. Biol. Chem. 277:2002;26927-26933.
47. Riedy M.C., Brown M.C., Molloy C.J., Turner C.E. Activin A and TGF-beta stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells. Exp. Cell Res. 251:1999;194-202.
48. Vadlamudi R., Adam L., Talukder A., Mendelsohn J., Kumar R. Serine phosphorylation of paxillin by heregulin-betal role of p38 mitogen activated protein kinase. Oncogene. 18:1999;7253-7264.
49. Brown M.C., Turner C.E. Characterization of paxillin LIM domain-associated serine threonine kinases activation by angiotensin II in vascular smooth muscle cells. J. Cell. Biochem. 76:1999;99-108.
50. Bellis S.L., Perrotta J.A., Curtis M.S., Turner C.E. Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin. Biochem. J. 325:1997;375-381.
51. Brown M.C., Perrotta J.A., Turner C.E. Serine and threonine phosphorylation of the paxillin LIM domains regulates paxillin focal adhesion localization and cell adhesion to fibronectin. Mol. Biol. Cell. 9:1998;1803-1816.
52. Terfera D.R., Brown M.C., Turner C.E. Epidermal growth factor stimulates serine/threonine phosphorylation of the focal adhesion protein paxillin in a MEK-dependent manner in normal rat kidney cells. J. Cell. Physiol. 191:2002;82-94.
53. Songyang Z., Lu K.P., Kwon Y.T., Tsai L.H., Filhol O., Cochet C., Brickey D.A., Soderling T.R., Bartleson C., Graves D.J., DeMaggio A.J., Hoekstra M.F., Blenis J., Hunter T., Cantley L.C. A structural basis for substrate specificities of protein Ser/Thr kinases primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16:1996;6486-6493.
54. McCarthy S.A., Chen D., Yang B.S., Garcia Ramirez J.J., Cherwinski H., Chen X.R., Klagsbrun M., Hauser C.A., Ostrowski M.C., McMahon M. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:1997;2401-2412.
55. Schlaepfer D.D., Hauck C.R., Sieg D.J. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71:1999;435-478.
56. Weisberg E., Sattler M., Ewaniuk D.S., Salgia R. Role of focal adhesion proteins in signal transduction and oncogenesis. Crit. Rev. Onco. 8:1997;343-358.
57. Sattler M., Pisick E., Morrison P.T., Salgia R. Role of the cytoskeletal protein paxillin in oncogenesis. Crit. Rev. Onco. 11:2000;63-76.
58. Turner C.E. Paxillin a cytoskeletal target for tyrosine kinases. Bioessays. 16:1994;47-52.
59. Young B.A., Taooka Y., Liu S., Askins K.J., Yokosaki Y., Thomas S.M., Sheppard D. The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner. Mol. Biol. Cell. 12:2001;3214-3225.
60. Wood C.K., Turner C.E., Jackson P., Critchley D.R. Characterisation of the paxillin-binding site and the C-terminal focal adhesion targeting sequence in vinculin. J. Cell Sci. 107:1994;709-717.
61. Nikolopoulos S.N., Turner C.E. Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J. Cell Biol. 151:2000;1435-1448.
62. Turner C.E., Brown M.C., Perrotta J.A., Riedy M.C., Nikolopoulos S.N., McDonald A.R., Bagrodia S., Thomas S., Leventhal P.S. Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein a role in cytoskeletal remodeling. J. Cell Biol. 145:1999;851-863.
63. Nikolopoulos S.N., Turner C.E. Integrin-linked kinase (ilk) binding to paxillin ld1 motif regulates ilk localization to focal adhesions. J. Biol. Chem. 276:2001;23499-23505.
64. Hashimoto S., Tsubouchi A., Mazaki Y., Sabe H. Interaction of paxillin with p21-activated Kinase (PAK) association of paxillin alpha with the kinase-inactive and the Cdc42-activated forms of PAK3. J. Biol. Chem. 276:2001;6037-6045.
65. Hildebrand J.D., Schaller M.D., Parsons J.T. Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol. Biol. Cell. 6:1995;637-647.
66. Tachibana K., Sato T., D'Avirro N., Morimoto C. Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J. Exp. Med. 182:1995;1089-1099.
67. Turner C.E. Molecules in focus paxillin. Int. J. Biochem. Cell Biol. 30:1998;955-959.
68. Brown M.C., Perrotta J.A., Turner C.E. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J. Cell Biol. 135:1996;1109-1123.
69. Greenberg S., Chang P., Silverstein S.C. Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. J. Biol. Chem. 269:1994;3897-3902.
70. Khan M.A., Okumura N., Okada M., Kobayashi S., Nakagawa H. Nerve growth factor stimulates tyrosine phosphorylation of paxillin in PC12h cells. FEBS Lett. 362:1995;201-204.
71. Hagel M., George E.L., Kim A., Tamimi R., Opitz S.L., Turner C.E., Imamoto A., Thomas S.M. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 22:2002;901-915.
72. Wade R., Bohl J., Vande Pol S. Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene. 21:2002;96-107.
73. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.